Cannabis Use among Older Persons with Arthritis, Cancer and Multiple Sclerosis: Are We Comparing Apples and Oranges?
Abstract
:1. Introduction
1.1. Background
1.2. Research Objectives
2. Materials and Methods
2.1. Survey Data
2.2. Sample
2.3. Analysis
3. Results
4. Discussion
Limitations
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Wallin, M.T.; Culpepper, W.J.; Campbell, J.D.; Nelson, L.M.; Langer-Gould, A.; Marrie, R.A. The prevalence of MS in the United States: A population-based estimate using health claims data. Neurology 2021, 92, e1029–e1040. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lublin, F.D.; Reingold, S.C.; Cohen, J.A.; Cutter, G.R.; Sørensen, P.S.; Thompson, A.J.; Polman, C.H. Defining the clinical course of multiple sclerosis: The 2013 revisions. Neurology 2014, 83, 278–286. Available online: https://pubmed.ncbi.nlm.nih.gov/24871874 (accessed on 20 January 2021). [CrossRef] [Green Version]
- Penner, I.; Hartung, H. The dark side of the moon: Looking beyond beneficial effects of cannabis use in multiple sclerosis. Brain 2019, 142, 2546–2557. [Google Scholar] [CrossRef]
- Rice, J.; Cameron, M. Cannabinoids for treatment of MS symptoms: State of the evidence. Curr. Neurol. Neurosci. Rep. 2018, 18, 50. [Google Scholar] [CrossRef]
- Yadav, V.; Bever, C., Jr.; Bowen, J.; Bowling, A.; Weinstock-Guttman, B.; Cameron, M.; Narayanaswami, P. Summary of evidence-based guideline: Complementary and alternative medicine in multiple sclerosis: Report of the guideline development subcommittee of the American Academy of Neurology. Neurology 2014, 82, 1083–1092. Available online: https://pubmed.ncbi.nlm.nih.gov/24663230 (accessed on 20 January 2021). [CrossRef] [Green Version]
- Cofield, S.S.; Salter, A.; Tyry, T.; Crowe, C.; Cutter, G.R.; Fox, R.J.; Marrie, R.A. Perspectives on marijuana use and effectiveness: A survey of NARCOMS participants. Neurol. Clin. Pract. 2017, 7, 333–343. Available online: https://pubmed.ncbi.nlm.nih.gov/29185555 (accessed on 20 January 2021). [CrossRef]
- Braley, T.J.; Whibley, D.; Alschuler, K.N.; Ehde, D.M.; Chervin, R.D.; Clauw, D.J.; Kratz, A.L. Cannabinoid use among Americans with MS: Current trends and gaps in knowledge. Mult. Scler. J. Exp. Transl. Clin. 2020. [Google Scholar] [CrossRef]
- Weinkle, L.; Domen, C.H.; Shelton, I.; Sillau, S.; Nair, K.; Alvarez, E. Exploring cannabis use by patients with multiple sclerosis in a state where cannabis is legal. Mult. Scler. Relat. Disord. 2019, 27, 383–390. Available online: https://pubmed.ncbi.nlm.nih.gov/30502644 (accessed on 20 January 2021). [CrossRef]
- Gupta, S.; Fellows, K.; Weinstock-Guttman, B.; Hagemeier, J.; Zivadinov, R.; Ramanathan, M. Marijuana Use by Patients with Multiple Sclerosis. Int. J. MS Care 2019, 21, 57–62. [Google Scholar] [CrossRef] [PubMed]
- Martínez-Rodríguez, J.E.; Munteis, E.; Carreño, M.; Blanco, Y.; Roquer, J.; Abanades, S.; Graus, F.; Saiz, A. Cannabis use in Spanish patients with multiple sclerosis. J. Neurol. Sci. 2008, 273, 103–107. [Google Scholar] [CrossRef] [PubMed]
- National Academies of Sciences, Engineering, and Medicine. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research; The National Academies Press: Washington, DC, USA, 2017; 468p. Available online: https://www.ncbi.nlm.nih.gov/books/NBK423845/pdf/Bookshelf_NBK423845.pdf (accessed on 3 October 2019). [CrossRef] [Green Version]
- Illinois Department of Public Health. Multiple Sclerosis. Available online: http://www.dph.illinois.gov/topics-services/diseases-and-conditions/chronic-diseases/ms (accessed on 3 February 2021).
- Martell, K.; Fairchild, A.; LeGerrier, B.; Sinha, R.; Baker, S.; Liu, H.; Ghose, A.; Olivotto, I.A.; Kerba, M. Rates of Cannabis Use in Patients with Cancer. Curr. Oncol. 2018, 25, 219–225. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kleckner, A.S.; Kleckner, I.R.; Kamen, C.S.; Tejani, M.A.; Janelsins, M.C.; Morrow, G.R.; Peppone, L.J. Opportunities for cannabis in supportive care in cancer. Ther. Adv. Med. Oncol. 2019. Available online: https://pubmed.ncbi.nlm.nih.gov/31413731 (accessed on 15 March 2021). [CrossRef] [PubMed] [Green Version]
- Almogi-Hazan, O.; Or, R. Cannabis, the Endocannabinoid System and Immunity—The Journey from the Bedside to the Bench and Back. Int. J. Mol. Sci. 2020, 21, 4448. [Google Scholar] [CrossRef] [PubMed]
- Croker, J.A., III; Bobitt, J.; Arora, K.; Kaskie, B. Assessing health-related outcomes of medical cannabis use among older persons: Findings from Colorado and Illinois. Clin. Gerontol. 2021, 44, 66–79. [Google Scholar] [CrossRef] [PubMed]
- Bobitt, J.; Kang, H.; Arora, K.; Bhagianadh, D.; Milavetz, G.; Kaskie, B. Offering an Opioid Alternative to Persons with Chronic Pain: How Preferences and Providers Influence Individual Decisions. under review.
- Choi, N.G.; DiNitto, D.M. Marijuana use/nonuse among those aged 50+: Comparisons of use-to-nonuse, initiation/reinitiation, and continued use over 24 months. Aging Ment. Health 2020. [CrossRef] [PubMed]
- Lucas, P.; Walsh, Z. Medical cannabis access, use, and substitution for prescription opioids and other substances: A survey of authorized medical cannabis patients. Int. J. Drug Policy 2017, 42, 30–35. Available online: https://pubmed.ncbi.nlm.nih.gov/28189912 (accessed on 15 March 2021). [CrossRef] [PubMed]
- Kang, H.; Hunniecutt, J.; Quintero Silva, L.; Kaskie, B.; Bobitt, J. Analysis of biopsychosocial factors and health outcomes associated with cannabis, opioids and benzodiazepines use among older Veterans. Am. J. Drug Alcohol Abus. 2021. [Google Scholar] [CrossRef]
- Ware, M.A.; Adams, H.; Guy, G.W. The Medicinal use of cannabis in the UK: Results of a nationwide survey. Int. J. Clin. Pract. 2005, 59, 291–295. [Google Scholar] [CrossRef]
- Harris, P.A.; Taylor, R.; Thielke, R.; Payne, J.; Gonzalez, N.; Conde, J.G. Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support. J. Biomed. Inform. 2009, 42, 377–381. [Google Scholar] [CrossRef] [Green Version]
- National Institute on Drug Abuse. Misuse of Prescription Drugs. 13 December 2018. Available online: https://www.drugabuse.gov/node/pdf/2609/misuse-of-prescription-drugsOpioids (accessed on 24 August 2018).
- Wahls, T.L.; Chenard, C.A.; Snetselaar, L.G. Review of Two Popular Eating Plans within the Multiple Sclerosis Community: Low Saturated Fat and Modified Paleolithic. Nutrients 2019, 11, 352. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Arthritis | Cancer | MS | ||
---|---|---|---|---|
N (%) | 586 (43.6) | 622 (46.3) | 135 (10.1) | p-value |
Control variables—N (%) | ||||
Cannabis for sleep | 395 (67.4) | 415 (66.7) | 78 (57.8) | 0.094 2 |
Cannabis for digestive issues | 101 (17.2) | 277 (44.5) | 24 (17.8) | <0.001 1,3 |
Cannabis for muscle spasticity | 2 (0.3) | 1 (0.2) | 21 (15.6) | <0.0012,3 |
Female | 321 (54.8) | 279 (44.9) | 88 (65.2) | <0.001 1,2,3 |
Education (college and above) | 238 (40.6) | 11 (50.0) | 75 (55.6) | <0.001 1,2 |
Financial status * | 398 (67.9) | 469 (75.4) | 95 (70.4) | 0.015 1 |
Past-year opioid use | 293 (50.0) | 258 (41.5) | 45 (33.3) | <0.001 1,2 |
Pain (mean (SD)) | 5.78 (2.09) | 4.36 (2.49) | 5.09 (2.30) | <0.001 1,2,3 |
Outcome variables—N (%) | ||||
Psychological wellbeing | 395 (67.4) | 402 (64.6) | 74 (54.8) | 0.022 2,3 |
Quality of life | 535 (91.3) | 536 (86.2) | 119 (88.1) | 0.019 1 |
Productivity | 386 (65.9) | 343 (55.1) | 69 (51.1) | <0.001 1,2 |
Exercise | 271 (46.2) | 227 (36.5) | 42 (31.1) | <0.001 1,2 |
Social satisfaction | 222 (37.9) | 208 (33.4) | 36 (26.7) | 0.032 2 |
Psychological Wellbeing | Quality of Life | Productivity | Exercise | Social Satisfaction | |
---|---|---|---|---|---|
N | 1343 | 1343 | 1343 | 1343 | 1343 |
Med Dx: | |||||
MS | 1.00 [Ref] | 1.00 [Ref] | 1.00 [Ref] | 1.00 [Ref] | 1.00 [Ref] |
Cancer | 1.12 [0.74, 1.71] | 0.68 [0.37, 1.27] | 1.16 [0.76, 1.77] | 1.16 [0.74, 1.80] | 1.11 [0.71, 1.75] |
Arthritis | 1.51 [1.00, 2.29] | 1.51 [0.80, 2.84] | 2.02 ** [1.33, 3.05] | 1.86 ** [1.21, 2.86] | 1.50 [0.96, 2.33] |
Cannabis for sleep | 1.42 ** [1.12, 1.81] | 1.93 *** [1.36, 2.74] | 1.52 *** [1.20, 1.93] | 1.44 ** [1.13, 1.83] | 1.35 * [1.06, 1.74] |
Cannabis for digestive issues | 1.82 *** [1.38, 2.40] | 2.06 ** [1.34, 3.17] | 1.74 *** [1.34, 2.27] | 1.55 ** [1.20, 2.00] | 1.59 *** [1.22, 2.06] |
Cannabis for muscle spasticity | 0.54 [0.22, 1.32] | 3.03 [0.38, 24.53] | 1.56 [0.62, 3.90] | 0.99 [0.39, 2.53] | 0.42 [0.13, 1.32] |
Female | 0.77 * [0.61, 0.97] | 0.53 ** [0.37, 0.76] | 1.16 [0.93, 1.46] | 0.96 [0.77, 1.20] | 0.97 [0.77, 1.22] |
Education | 0.90 [0.71, 1.13] | 1.10 [0.77, 1.57] | 0.90 [0.72, 1.13] | 0.92 [0.73, 1.15] | 0.85 [0.67, 1.08] |
Financial status | 0.86 [0.66, 1.13] | 1.00 [0.67, 1.49] | 1.03 [0.79, 1.33] | 0.82 [0.64, 1.06] | 0.85 [0.66, 1.11] |
Past-year opioid use | 0.77 * [0.60, 0.99] | 0.51 *** [0.35, 0.74] | 0.63 *** [0.49, 0.80] | 0.75 * [0.59, 0.96] | 0.70 ** [0.55, 0.90] |
Pain | 1.01 [0.96, 1.07] | 1.04 [0.97, 1.13] | 1.06 * [1.00, 1.12] | 1.04 [0.99, 1.10] | 1.02 [0.97, 1.08] |
Constant | 1.32 [0.74, 2.34] | 6.62 *** [2.82, 15.54] | 0.57 [0.33, 1.01] | 0.38 ** [0.21, 0.68] | 0.38 ** [0.21, 0.68] |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Kaskie, B.; Kang, H.; Bhagianadh, D.; Bobitt, J. Cannabis Use among Older Persons with Arthritis, Cancer and Multiple Sclerosis: Are We Comparing Apples and Oranges? Brain Sci. 2021, 11, 532. https://doi.org/10.3390/brainsci11050532
Kaskie B, Kang H, Bhagianadh D, Bobitt J. Cannabis Use among Older Persons with Arthritis, Cancer and Multiple Sclerosis: Are We Comparing Apples and Oranges? Brain Sciences. 2021; 11(5):532. https://doi.org/10.3390/brainsci11050532
Chicago/Turabian StyleKaskie, Brian, Hyojung Kang, Divya Bhagianadh, and Julie Bobitt. 2021. "Cannabis Use among Older Persons with Arthritis, Cancer and Multiple Sclerosis: Are We Comparing Apples and Oranges?" Brain Sciences 11, no. 5: 532. https://doi.org/10.3390/brainsci11050532
APA StyleKaskie, B., Kang, H., Bhagianadh, D., & Bobitt, J. (2021). Cannabis Use among Older Persons with Arthritis, Cancer and Multiple Sclerosis: Are We Comparing Apples and Oranges? Brain Sciences, 11(5), 532. https://doi.org/10.3390/brainsci11050532